News

The inauguration of Martha E. Pollack as the 14th president of Cornell University will feature student scholarship, highlight the role of universities in the search for truth, and celebrate the community Aug. 24 and 25.

The 107 students in the Class of 2021 shared in a celebration on Aug. 15 that marked a milestone in their lives: the annual White Coat Ceremony.

ARCADIA, a multicenter phase III trial, will study the role of abnormalities in the structure and function of the heart’s left atrium, or atrial cardiopathy, in stroke patients, and test a medication that could prevent them from experiencing recurrent strokes.

NewYork-Presbyterian/Weill Cornell Medical Center has been verified as a Level I Adult and a Level II Pediatric Trauma Center by the American College of Surgeons’ Committee on Trauma.

Dr. Gregory Sonnenberg, an assistant professor of microbiology and immunology at Weill Cornell Medicine, has received the newly established Young Investigator Award from the Society for Mucosal Immunology.

NewYork-Presbyterian Hospital, one of the largest and most comprehensive academic medical centers in the nation, is ranked New York’s No. 1 hospital for the 17th consecutive year, and No. 8 in the United States, according to the U.S. News and World Report annual survey of “Best Hospitals,” published online today.

States that require prescribers to register for prescription drug monitoring programs have seen a reduction in the number of prescriptions issued for Schedule II opioids to Medicaid enrollees by up to 10 percent, according to research from Weill Cornell Medicine investigators.

Dr. Robert Burakoff has been named vice chair for ambulatory services for the Weill Department of Medicine at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, and site chief for the Division of Gastroenterology and Hepatology at NewYork-Presbyterian Lower Manhattan Hospital and Weill Cornell Medicine.

Dr. Robert Min has been appointed president and chief executive officer of Weill Cornell Medicine’s Physician Organization, effective Jan. 1. Dr. Adam Stracher has been named chief medical officer of the physician organization and promoted to associate dean for clinical affairs.

Awards, honors, prizes and achievements for the month of July. 

A compound used in traditional Chinese medicine to lower blood pressure also strongly combats Zika virus infection of the brain, and may protect against Zika-associated birth defects, according to a new study by Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center scientists. 

Dr. Michael G. Stewart is taking on an expanded role as vice dean at Weill Cornell Medicine, and Dr. Peter N. Schlegel has been appointed senior associate dean for clinical affairs.

Dr. Bishoy Faltas, an assistant professor of medicine at Weill Cornell Medicine and an oncologist at New York Presbyterian/Weill Cornell Medical Center, has been awarded a Career Development Award from the Department of Defense to investigate the biology of a family of proteins thought to drive resistance to chemotherapy in the advanced stages of bladder cancer.

Two Weill Cornell Medicine investigators have received 2017 Clinical Scientist Development Awards from the Doris Duke Charitable Foundation to support their ongoing research projects. 

Alexandra Lebenthal can’t recall a time growing up when her hands didn’t shake uncontrollably. Since age three, she has dealt with essential tremor, a neurological disorder that left her struggling with everyday activities like cutting food, pouring drinks and holding a pen.

Dr. Hugh Hemmings, Jr. has been appointed senior associate dean for research and Dr. Todd Evans has been appointed associate dean for research at Weill Cornell Medicine.

A protein found in the cells lining blood vessels plays a central role in preventing fluid and inflammatory cells from leaking into lung tissue in a low-oxygen environment, Weill Cornell Medicine researchers discovered.

Genetic mutations caused by rearranged chromosomes drive the development and growth of certain colorectal cancers, according to new research conducted by Weill Cornell Medicine investigators.

By studying the effects of immune cells that surround blood vessels in the brain, Weill Cornell Medicine researchers have discovered a new pathway involving these cells that may contribute to the cause of Alzheimer’s disease.